Press Releases

Press Releases

Feb 17, 2011
Pipeline Development Continues to Advance as Transformation to a Biotechnology Company is Complete PISCATAWAY, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its fourth-quarter and full-year 2010 financial results.
Feb 10, 2011
PISCATAWAY, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it will report its financial results for the quarter ended December 31, 2010 , on Thursday, February 17, 2011 at 4:00 pm Eastern Time (ET).
Jan 10, 2011
BRIDGEWATER, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration ( FDA ) and plan to commence enrollment into a Phase 1a/ 1b study shortly.
Dec 21, 2010
BRIDGEWATER, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that the Company's Board of Directors has authorized the purchase of up to $200 million of outstanding shares of the Company's common stock.
Dec 15, 2010
BRIDGEWATER, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced the initiation of Phase I clinical studies, in collaboration with the National Cancer Institute (NCI), for two of the Company's novel oncology product candidates, EZN-2968 and EZN-2208 (PEG-SN38).
Nov 17, 2010
Third-Generation mRNA-Targeting Compounds Show Potent Anti-Tumor Activity BRIDGEWATER, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists.
Nov 2, 2010
BRIDGEWATER, N.J., Nov 02, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the third quarter of 2010.
Nov 2, 2010
BRIDGEWATER, N.J., Nov 02, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.
Oct 29, 2010
BRIDGEWATER, N.J., Oct 29, 2010 (BUSINESS WIRE) -- Second graph of release, the time zones should be CET. (sted, CEST).
Oct 29, 2010
BRIDGEWATER, N.J., Oct 29, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.